INTRODUCTION
Liposarcoma is one of the most common mesenchymal neoplasms [1] , and liposarcomas are classified histologically into five subtypes [2] . However liposarcoma of the stomach is rare, and only 37 cases have been reported in the literature. Liposarcoma of the stomach is mainly located in the antrum, and it is usually of submucosal origin. Definitive diagnosis is reached only by histopathological examination. Because of the low incidence of this tumor, treatment of gastric liposarcoma is still not well-standardized. However, the prognosis may remain satisfactory if the condition is diagnosed early and treated appropriately. Herein, two cases of liposarcoma of the stomach are described, and we also discuss the histopathological types, etiology, diagnosis, and treatment strategies in this report.
CASE REPORT
In the Chinese Academy of Medical Sciences Cancer Hospital we encountered two cases, one in 2009 and one in 2016.
Case 1
The first patient was a 45-year-old woman who presented with the symptom of upper abdominal discomfort, which she had experienced for 6 mo. She complained of abdominal pain without any fever or gastrointestinal bleeding. During the physical examination, no special physical signs were found.
The gastroscopy revealed a large tumor mass about 5 cm in diameter located in the junction of the body and fundus of the stomach; it had been considered a benign tumor. Computed tomography confirmed a spherical tumor in the stomach, which was approximately 5.6 cm × 4.2 cm × 3.5 cm in size. The border of the tumor was clear and presented a significantly strengthened edge, and the center of the tumor was inhomogeneous. There were no visible signs of metastatic disease. Upper gastrointestinal imaging also found a circular tumor with smooth edges. The patient had no distinctive past medical history and denied any relevant family history. On March 30, 2009 , the patient underwent a resection of the stomach tumor, and surgeons resected part of the omentum. An intraoperative pathology freezing study revealed mesenchymal neoplasms.
She had an uneventful recovery and was discharged after 9 d. The patient did not undergo any adjuvant treatment. She has remained under close follow-up supervision and is currently disease free.
The histopathological examination revealed a welldifferentiated liposarcoma measuring 6 cm × 5 cm × 4 cm, which had infiltrated the muscle and serosal layers of the gastric wall ( Figure 1 ). The immunohistochemistry finds were S-100+, CD34++, SMA+, Desmin++, CD117-, HMB45-, and Ki-67 < 1%. Fluorescent in situ hybridization (FISH) detection showed amplification of the MDM2 gene (Figure 2 ).
Case 2
A 69-year-old man was admitted to our department because of upper abdominal discomfort combined with nausea and anorexia that he had been experiencing for about 6 mo. During this period he lost 10 kg in weight. At first he pursued treatment with traditional Chinese medicine, and his symptoms were relieved. He underwent pituitary surgery in 2014 because of a pituitary tumor, and he had suffered from hypertension for 30 years. As a result of regular medication, his blood pressure was well controlled. His family history was unremarkable.
Our hospital's endoscopic examination showed that a limited knurl was distributed from the lower part of the gastric body to the corner of the stomach ( Figure 3A) , and a knurl was also found in the gastric fundus (figure 3B). Multiple biopsies were obtained, but they were all superficial and showed only unspecific inflammation of the gastric mucosa. Gastric endoscopic ultrasound (EUS) examination revealed that the tumor was mainly located in the submucosa of the gastric wall and was potentially a liposarcoma ( Figure 4) . Computed tomography confirmed a fat density tumor about 5.1 cm × 2.8 cm in size. No hepatic metastasis or nodal involvements were detected.
On August 1, 2016, an endoscopic submucosal dissection (ESD) was performed ( Figure 5 ). During the operation, we found that the surface of the tumor was complete and smooth, and the substrate was sturdy. The operation was successful without any complications. The postoperative course was uneventful, and the patient was discharged on postoperative day 7. He did not undergo any adjuvant treatment and remained free of metastasis 20 mo after surgery.
The histopathological diagnosis was a well-differentiated liposarcoma (Figures 6 and 7) . FISH testing demonstrated amplification of the MDM2 gene ( Figure 8 ).
DISCUSSION
Liposarcoma, a kind of malignant tumor of mesenchymal origin, is one of the most common soft tissue sarcomas [1] . However, liposarcoma of the stomach is extremely rare. The first case was reported by Abrama and Tuberville in 1941, and until now only 37 cases (with a mean age of 57.0 years) have been reported worldwide (Table 1) .
According to the 2013 WHO classification of soft tissue tumors, liposarcoma is a malignant fat cell tumor that can be histologically subdivided into the following five types: atypical lipomatous tumor/well differentiated liposarcoma, dedifferentiated liposarcoma, myxoid liposarcoma, pleomorphic liposarcoma, and liposarcoma, not otherwise specified [2] . Both of our cases had well-differentiated liposarcomas. Well-differentiated liposarcoma (including atypical lipomas) is the most common subtype, accounting for about 40%-45% of all liposarcomas [3] . Under the common subtype is myxoid liposarcoma, which represents about a third of all liposarcomas [3] . Myxoid liposarcoma is characterized by a myxoid matrix [6] . Under the microscope, its cells look less normal and may have a high grade component. Tumor cells infiltrate blood vessels in the fibromyxoid stroma that form characteristic clusters or branches. Therefore, we usually categorize myxoid liposarcomas as intermediate to high microscope, the tumor cells look like normal fat cells. This kind of liposarcoma is usually a low-grade tumor in the early stages and grows slowly [4] . There is a risk of local recurrence but a low potential for metastasis [5] . Dedifferentiated liposarcomas and well-differentiated liposarcomas are related [1] . Approximately 10% of dedifferentiated liposarcomas are recurrences of well-differentiated liposarcomas [3] . The second most grade tumors. Pleomorphic liposarcoma is considered the least common subtype and has been properly characterized only recently. It accounts for approximately 5% of liposarcomas and is a highly malignant lesion [7] . Pleomorphic liposarcoma is characterized by increased mitotic activity and hemorrhage as well as necrosis [8] . [20] 77 M S + radiation 15 × 8 × 6 antrum Unknown WR in 8 mo 3 1965 Hawkins et al [21] 86 M S 10 × 10 fundus MY WR in 24 mo 4 1968 Orita et al [22] 42 M S 1.2 × 1.0 × 1.0 body Unknown WR 60 mo 5
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2007 Konstantinos et al [6] 68 M T 9 × 4 fundus WD WR in 24 mo 28 2007 Michiels et al [7] 27 F These tumors can appear anywhere in the body but often occur in the limbs and retroperitoneal space, and the rest occur in the head and neck, abdominal wall, chest wall, and other areas. Liposarcomas hardly ever occurs in organs [6] and are mainly found in adults, with a peak incidence between the age of 50 and 65 years [4] . The origin of gastric liposarcomas is likely the proliferation of undifferentiated mesenchymal cells within the submucosa and the tunica muscularis layer of the stomach [9] . Gastric liposarcomas are characterized by an exophytic growth that adheres to the gastric wall, and the typical location of gastric liposarcomas is the antrum. According our statistics, approximately 30.8% (8/26) of gastric liposarcomas are located in the antrum, and they are usually of submucosal origin. In addition, 23.1% (6/26) of gastric liposarcomas are located in the minor curvature, 15.4% (4/26) in the fundus, 15.4% (4/26) in the body, 11.5% (3/26) in the greater curvature, and 3.8% (1/26) in the gastroesophageal junction. The diameter of the tumors described in the literature varies from 0.5 to 36 cm.
The etiology of liposarcoma is not yet clear; environmental factors, radiation, genetic variation, and immune defects are potential risk factors [10] . Some patients have a familial history of soft tissue tumors [4] , which suggests genetic factors may play an important role in the occurrence of gastric liposarcoma.
Because the tumor develops within the gastric wall, it presents an extra-luminal growth, and the patient can remain asymptomatic for a long time. The symptoms of gastric liposarcoma range from dyspepsia, nausea, vomiting, anorexia, abnormal bowel movements, asthenia, and epigastric abdominal pain to upper gastrointestinal tract bleeding. The type of symptom that appears depends on the location and size of the tumor and the presence of ulcerations [3] . Space-occupying lesions of the stomach or abdominal cavity contribute to the appearance of clinical symptoms [1] . When the submucosal mass extrudes into the lumen, it can cause traumatic and inflammatory changes and result in necrosis, ulceration, and hemorrhage [11] . For patients with giant tumors, the main clinical sign may be the presence of a large abdominal mass of unknown origin [3] . In our cases, the main clinical sign in both patients was epigastric abdominal pain that continued for longer than 6 mo. In both cases, the typical exophytic growth explains the lack of specific gastrointestinal symptoms and the delayed diagnosis [12] . Some cases of gastric liposarcoma can involve other organs synchronously, and unique symptoms may be present [13, 14] . Unfortunately, because of the lack of specific symptoms, it is difficult to achieve an early diagnosis [7] . The diagnosis of gastric liposarcoma mainly relies on pathological examination. Cytogenetics and molecular biology provide effective tools for differentiating among types of lipomatous tumors [11] . Macroscopically, liposarcoma present intricate myxomatous zones, which include round cells, pleomorphous clearly differentiated lipoblastic aspects, and hemorrhagic areas [15] . Because endoscopic biopsies do not penetrate the submucosa, the diagnostic value of the endoscopy is unclear, and it is difficult to make a precise judgment on the basis of biopsy findings. Endoscopic biopsies may be useful when the tumor presents endoluminal development. With the guidance of EUS or abdominal ultrasound, biopsy may be possible, and a histological examination, immunohistochemistry, and a cytogenetic study can be performed [3] . Detection of MDM2 is probably important in diagnosis. In terms of imaging, computed tomography is considered the most informative examination. The presence of fat density areas is pathognomonic for fatty tumors, and an association with enhanced areas is highly suggestive of the diagnosis [16] . CT scans can also show secondary lesions in the liver, lung, peritoneum, or other places.
Currently, the main therapy for gastric liposarcoma is surgical removal. The type of gastrectomy chosen depends on the location of the tumor. According to the rules of sarcoma resection, surgeons should resect the tumor with a wide margin of healthy tissue around it and make sure there is no remaining tumor tissue [3] . Lymph node dissection may be unnecessary [17] . One of our patients underwent a ESD. Due to the lack of sufficient data, the advantages and disadvantages of this method are unknown. In consideration of the successful application of ESD in early gastric cancer, we believe this method is available for a low-grade tumor in the early stages. Chemotherapy and radiotherapy combined with surgery have been successful in most malignant tumors; however, we still cannot develop a guideline for chemotherapy and radiotherapy in patients with gastric liposarcoma. There is very little information in the literature about the use of chemotherapy for gastric liposarcoma. Because of a high local recurrence rate of 70%-90% for high-grade soft-tissue sarcomas [18] , adjuvant therapy may be necessary. On the contrary, Matone et al [4] hold the opinion that there is currently no evidence that chemotherapy or radiotherapy improves survival rates. Three drugs, ifosfamide, doxo/epirubicin, and dacarbazine are active in the therapy of adult soft tissue sarcoma [7] ; they provide a potential therapeutic pathway for gastric liposarcoma. Radiation therapy may be beneficial by killing tumor cells and reducing the chance of the tumor returning in the same location [3] and may be widely used in the treatment of sarcoma. Only six cases reported in the literature received adjuvant treatment. In our cases, patients did not undergo any adjuvant or neoadjuvant therapy. Both patients are free from recurrence after sarcoma resection.
The main prognostic factor for the primary tumor is histological type, and other factors include the scope and location of the tumor [7] . Kim et al [19] believe the main prognostic factor for the primary tumor is anatomical location. According to our statistics, mortality associated with gastric liposarcoma is usually found in cases of dedifferentiated liposarcoma, myxoid liposarcoma, pleomorphic liposarcoma, and mixed type liposarcoma. Of the 37 cases described, six patients died of the disease, while the outcome for nine patients is not known. Their survival time ranged from sudden death to 18 mo (specifically, the times were immediate, 55 d, 4 mo, 11 mo, 16 mo, and 18 mo). Some studies reported that 30% of well-differentiated liposarcomas present with local recurrence; however, metastasis is hardly ever seen [1, 4] . Pleiomorphic liposarcoma is considered a highly malignant lesion and may indicate a poor outcome [7] . Due to the lack of sufficient data, we still cannot clearly determine the relationship between histological type and disease prognosis. The outcome of gastric liposarcoma is still unclear, and further study is needed.
From the reported cases and literature review [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] , we conclude that liposarcoma is rarely seen in the viscera, especially the stomach. Diagnosis of this tumor mainly depends on histopathological examination. Gastric liposarcomas are extremely rare tumors for which there is no therapeutic consensus. Although medications and devices have improved in recent years, surgery may be the most reasonable treatment, and the role of adjuvant treatment is not clearly defined. The prognosis is still unclear, and more research is needed. However, we believe that if the tumor is diagnosed early and treated effectively, the postoperative outcome may be positive.
ARTICLE HIGHLIGHTS

Case characteristics
Epigastric abdominal pain that continued for longer than 6 mo.
Clinical diagnosis
Gastrointestinal stromal tumor (GIST) and gastric lipoma.
Differential diagnosis
Differential diagnosis: GIST and gastric lipoma. Definitive diagnosis is reached only by histopathological examination.
Laboratory diagnosis
Gastric liposarcoma.
Imaging diagnosis
Computed tomography: Gastric lipoma.
Pathological diagnosis
Treatment
Partial gastrectomy and endoscopic submucosal dissection.
Related reports
The first case was reported by Abrama and Tuberville in 1941, and until now only 37 cases have been reported worldwide (Table 1) .
Term explanation
Two cases of gastric liposarcoma are reported and a review of the literature.
Experiences and lessons
Diagnosis of gastric liposarcoma mainly depends on histopathological examination, and surgery may be the most reasonable treatment.
